Discovery of Novel Inhibitors for Nek6 Protein Through Homology Model Assisted Structure Based Virtual Screening and Molecular Docking Approaches

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2014 Mar 4

PMID 24587765

Citations 6

Authors

P Srinivasan

P Chella Perumal

A Sudha

Affiliations

Soon will be listed here.

Abstract

Nek6 is a member of the NIMA (never in mitosis, gene A)-related serine/threonine kinase family that plays an important role in the initiation of mitotic cell cycle progression. This work is an attempt to emphasize the structural and functional relationship of Nek6 protein based on homology modeling and binding pocket analysis. The three-dimensional structure of Nek6 was constructed by molecular modeling studies and the best model was further assessed by PROCHECK, ProSA, and ERRAT plot in order to analyze the quality and consistency of generated model. The overall quality of computed model showed 87.4% amino acid residues under the favored region. A 3 ns molecular dynamics simulation confirmed that the structure was reliable and stable. Two lead compounds (Binding database ID: 15666, 18602) were retrieved through structure-based virtual screening and induced fit docking approaches as novel Nek6 inhibitors. Hence, we concluded that the potential compounds may act as new leads for Nek6 inhibitors designing.

Citing Articles

(5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms.

Palanisamy C, Cui B, Zhang H, Jayaraman S, Rajagopal P, Veeraraghavan V Bioinorg Chem Appl. 2022; 2022:4464056.

PMID: 35132312 PMC: 8817890. DOI: 10.1155/2022/4464056.

Screening of Potential Phytocompounds From (Thunb.) Leaves Targeting Human Epidermal Growth Factor Receptor 2 (HER2) Signaling Pathway.

Palanisamy C, Ashafa A J Pharm Bioallied Sci. 2019; 11(2):155-161.

PMID: 31148892 PMC: 6537645. DOI: 10.4103/jpbs.JPBS_61_18.

Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.

De Donato M, Righino B, Filippetti F, Battaglia A, Petrillo M, Pirolli D Sci Rep. 2018; 8(1):16047.

PMID: 30375481 PMC: 6207720. DOI: 10.1038/s41598-018-34471-y.

In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.

Wells C, Kapadia N, Counago R, Drewry D Medchemcomm. 2018; 9(1):44-66.

PMID: 30108900 PMC: 6071746. DOI: 10.1039/c7md00510e.

In vitro and in silico characterization of angiogenic inhibitors from Sophora interrupta.

Mathi P, Veeramachaneni G, Raj K, Talluri V, Bokka V, Botlagunta M J Mol Model. 2016; 22(10):247.

PMID: 27683258 DOI: 10.1007/s00894-016-3102-1.

References

Sumathi K, Ananthalakshmi P, Roshan M, Sekar K . 3dSS: 3D structural superposition. Nucleic Acids Res. 2006; 34(Web Server issue):W128-32. PMC: 1538824. DOI: 10.1093/nar/gkl036. View

Jee H, Kim H, Kim A, Song N, Kim M, Yun J . Nek6 suppresses the premature senescence of human cancer cells induced by camptothecin and doxorubicin treatment. Biochem Biophys Res Commun. 2011; 408(4):669-73. DOI: 10.1016/j.bbrc.2011.04.083. View

Delaine T, Bernardes-Genisson V, Quemard A, Constant P, Meunier B, Bernadou J . Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents. Eur J Med Chem. 2010; 45(10):4554-61. DOI: 10.1016/j.ejmech.2010.07.016. View

Sherman W, Day T, Jacobson M, Friesner R, Farid R . Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem. 2006; 49(2):534-53. DOI: 10.1021/jm050540c. View

Nassirpour R, Shao L, Flanagan P, Abrams T, Jallal B, Smeal T . Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target. Mol Cancer Res. 2010; 8(5):717-28. DOI: 10.1158/1541-7786.MCR-09-0291. View

Amaro R, Swift R, McCammon J . Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei. PLoS Negl Trop Dis. 2007; 1(2):e68. PMC: 2100368. DOI: 10.1371/journal.pntd.0000068. View

Eswar N, Eramian D, Webb B, Shen M, Sali A . Protein structure modeling with MODELLER. Methods Mol Biol. 2008; 426:145-59. DOI: 10.1007/978-1-60327-058-8_8. View

Wiederstein M, Sippl M . ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007; 35(Web Server issue):W407-10. PMC: 1933241. DOI: 10.1093/nar/gkm290. View

Jee H, Kim A, Song N, Kim H, Kim M, Koh H . Nek6 overexpression antagonizes p53-induced senescence in human cancer cells. Cell Cycle. 2010; 9(23):4703-10. DOI: 10.4161/cc.9.23.14059. View

10.

Wu B, Zhang Y, Kong J, Zhang X, Cheng S . In silico predication of nuclear hormone receptors for organic pollutants by homology modeling and molecular docking. Toxicol Lett. 2009; 191(1):69-73. DOI: 10.1016/j.toxlet.2009.08.005. View

11.

Lee M, Kim H, Kim M, Jee H, Kim A, Bae Y . Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation. Cell Cycle. 2008; 7(17):2705-9. PMC: 3769414. DOI: 10.4161/cc.7.17.6551. View

12.

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

13.

Malumbres M, Barbacid M . Cell cycle kinases in cancer. Curr Opin Genet Dev. 2007; 17(1):60-5. DOI: 10.1016/j.gde.2006.12.008. View

14.

Colovos C, Yeates T . Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993; 2(9):1511-9. PMC: 2142462. DOI: 10.1002/pro.5560020916. View

15.

Sherr C . Cancer cell cycles. Science. 1996; 274(5293):1672-7. DOI: 10.1126/science.274.5293.1672. View

16.

Singh K, Kirubakaran P, Nagarajan S, Sakkiah S, Muthusamy K, Velmurgan D . Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease. J Mol Model. 2011; 18(1):39-51. DOI: 10.1007/s00894-011-1018-3. View

17.

Umamaheswari A, Pradhan D, Hemanthkumar M . Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase. J Chem Biol. 2011; 3(4):175-87. PMC: 2957891. DOI: 10.1007/s12154-010-0040-8. View

18.

Sun M, Li Z, Zhang Y, Zheng Q, Sun C . Homology modeling and docking study of cyclin-dependent kinase (CDK) 10. Bioorg Med Chem Lett. 2005; 15(11):2851-6. DOI: 10.1016/j.bmcl.2005.03.088. View

19.

Fry A, Nigg E . Characterization of mammalian NIMA-related kinases. Methods Enzymol. 1997; 283:270-82. DOI: 10.1016/s0076-6879(97)83022-4. View

20.

Schwede T, Kopp J, Guex N, Peitsch M . SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 2003; 31(13):3381-5. PMC: 168927. DOI: 10.1093/nar/gkg520. View